• Exchange: Athens
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

LAVI:GA

0.1240 EUR 0.0010 0.81%

As of 10:10:25 ET on 10/24/2014.

Snapshot for Lavipharm SA (LAVI)

Open: 0.1250 Day's Range: 0.1220 - 0.1250 Volume: 1,000
Previous Close: 0.1230 52wk Range: 0.1000 - 0.1880 1-Yr Rtn: -12.68%

Stock Chart for LAVI

No chart data available.
  • LAVI:GA 0.1240
  • 1D
  • 1M
  • 1Y
0.1230
Interactive LAVI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LAVI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. FTASE -
Earnings Per Share (ttm) -0.5627
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 6.33
Shares Outstanding (M) 51.08
30 Day Average Volume 10,099
Price/Book (mrq) -
Price/Sale (ttm) 0.2210
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 06/05/2009
5 Year Dividend Growth -
Next Earnings Announcement 11/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LAVI

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for LAVI

Lavipharm S.A. develops, produces, promotes, trades, and distributes cosmetics and pharmaceuticals. The Company also represents overseas drug and cosmetics companies including Avon, Hoffman La Roche, Schering Plough, 3M, and Murdipharma.

Athanase LavidasChairman/CEOTania-Panagiota VranopoulouDeputy CEO
Telemaque Jean LavidasChief Commercial OfficerSpyridon FotinosChief Scientific Officer
More Company Profile & Key Executives for LAVI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil